Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

ClinicalTrials.gov ID: NCT03142451

Public ClinicalTrials.gov record NCT03142451. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam Compared to Vehicle in the Treatment of Facial Papulopustular Rosacea (FX2016-11)

Study identification

NCT ID
NCT03142451
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vyne Therapeutics Inc.
Industry
Enrollment
751 participants

Conditions and interventions

Interventions

  • FMX103 minocycline foam 1.5% Drug
  • Vehicle foam Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 1, 2017
Primary completion
Aug 30, 2018
Completion
Sep 27, 2018
Last update posted
Jan 28, 2021

2017 – 2018

United States locations

U.S. sites
54
U.S. states
20
U.S. cities
49
Facility City State ZIP Site status
Foamix Investigational Site #152 Tucson Arizona 85712
Foamix Investigational Site # 127 Fremont California 94538
Foamix Investigational Site #155 Los Angeles California 90036
Foamix Investigational Site #143 Northridge California 91324
Foamix Investigational Site # 131 Oceanside California 92056
Foamix Investigational Site #156 Oceanside California 92056
Foamix Investigational Site #153 San Diego California 92103
Foamix Investigational Site # 114 San Diego California 92123
Foamix Investigational Site # 116 San Luis Obispo California 93405
Foamix Investigational Site # 135 Santa Ana California 92705
Foamix Investigational Site # 123 Santa Monica California 90403
Foamix Investigational Site # 109 Clearwater Florida 33757
Foamix Investigational Site # 112 Hialeah Florida 33016
Foamix Investigational Site #150 Lake Worth Florida 33467
Foamix Investigational Site #149 Miami Florida 33126
Foamix Investigational Site #151 Miami Florida 33144
Foamix Investigational Site #144 Miami Lakes Florida 33016
Foamix Investigational Site # 104 Ormond Beach Florida 32174
Foamix Investigational Site # 121 Sanford Florida 32771
Foamix Investigational Site #154 Sweetwater Florida 33172
Foamix Investigational Site # 125 Tampa Florida 33609
Foamix Investigational Site # 142 West Palm Beach Florida 33406
Foamix Investigational Site # 124 West Palm Beach Florida 33409
Foamix Investigational Site # 118 Alpharetta Georgia 30022
Foamix Investigational Site # 139 Snellville Georgia 30078
Foamix Investigational Site # 138 New Albany Indiana 47150
Foamix Investigational Site # 102 Metairie Louisiana 70006
Foamix Investigational Site # 115 New Orleans Louisiana 70115
Foamix Investigational Site # 110 Beverly Massachusetts 01915
Foamix Investigational Site # 107 Brighton Massachusetts 02135
Foamix Investigational Site # 137 Ann Arbor Michigan 48103
Foamix Investigational Site # 103 Fort Gratiot Michigan 48059
Foamix Investigational Site # 120 Troy Michigan 48084
Foamix Investigational Site # 140 Warren Michigan 48088
Foamix Investigational Site # 130 Saint Joseph Missouri 64506
Foamix Investigational Site # 133 Omaha Nebraska 68144
Foamix Investigational Site #146 Las Vegas Nevada 89148
Foamix Investigational Site # 136 New York New York 10075
Foamix Investigational Site #145 New York New York 10155
Foamix Investigational Site # 111 Stony Brook New York 11790
Foamix Investigational Site # 119 Charlotte North Carolina 28277
Foamix Investigational Site # 101 Bexley Ohio 43209
Foamix Investigational Site # 128 Dublin Ohio 43016
Foamix Investigational Site #147 Broomall Pennsylvania 19008
Foamix Investigational Site # 141 Jenkintown Pennsylvania 19046
Foamix Investigational Site #157 Saint Clair Pennsylvania 15241
Foamix Investigational Site # 129 Yardley Pennsylvania 19067
Foamix Investigational Site # 105 Johnston Rhode Island 02919
Foamix Investigational Site # 106 Greenville South Carolina 29607
Foamix Investigational Site # 122 Murfreesboro Tennessee 37130
Foamix Investigational Site # 117 Austin Texas 78759
Foamix Investigational Site #159 Houston Texas 77074
Foamix Investigational Site # 108 San Antonio Texas 78213
Foamix Investigational Site # 126 Salt Lake City Utah 84117

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03142451, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03142451 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →